Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Gene Editing Market By Product, Technology and Application - Global Industry Analysis And Forecast To 2025

  • CRY2872032
  • 160 Pages
  • December 2018
  • Healthcare
Download Sample    Get Discount   
 
Gene Editing Market By Product (Instruments, Cell Lines & Animal Models and Software And Reagents and Consumables); Technology (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Zinc Finger Nucleases (ZFN), Transcriptor-Activator-Like Effector Nuclease (TALEN) and Other) and Application (Biotechnology, Drug Discovery & Development, Agriculture and Scientific Research) - Global Industry Analysis And Forecast To 2025

Industry Outlook

Gene editing is also referred to as genome editing. Genome is defined as the full DNA strand. Gene Editing is a procedure carried out to cut and replace a part of living organism. Gene Editing has various applications in sectors like agriculture (for increasing the output, developing crops that are tolerant to diseases and environmental changes); industrial biotechnology (for developing different materials, chemicals, pharmaceuticals, etc.); reproduction (for removing any traces of hereditary disease); etc. Gene editing is seen as a hopeful procedure for eradicating disorders and developing a good product in the field of genetic research. Therefore these are the factors due to which, the Gene Editing Market is anticipated to expand and has tremendous scope during the forecast period. The global Gene Editing Market is anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Gene Editing Market is based on segment, by Product the market is segmented into Instruments, Cell Lines & Animal Models and Software And Reagents and Consumables; by Technology the market is segmented into Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Zinc Finger Nucleases (ZFN), Transcriptor-Activator-Like Effector Nuclease (TALEN) and Other; and by Application the market is segmented into Biotechnology, Drug Discovery & Development, Agriculture and Scientific Research.

Gene Editing Market, By Product

Instruments

Cell Lines & Animal Models and Software

Reagents and Consumables

Gene Editing Market, By Technology

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

Zinc Finger Nucleases (ZFN)

Transcriptor-Activator-Like Effector Nuclease (TALEN)

Other

Gene Editing Market, Application

Biotechnology

Drug Discovery & Development

Agriculture

Scientific Research

Regional Insights

On a global front, the Gene Editing Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, South Africa, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). Gene Editing Market is led by North American region due to use of recent gene editing beforehand, number of key companies being present and increasing knowledge regarding the technology.

Gene Editing Market, By Region

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Russia

Italy

Rest of Europe

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Rest of Asia-Pacific

South America

Brazil

Argentina

Columbia

Rest of South America

Middle East and Africa

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Rest of MEA

Competitive Analysis

The leading players in the market are Sangamo Biosciences, Parker Institute, Editas Medicine, Intellia Therapeutics, Thermo Fisher Scientific, Cellectis, Crispr Therapeutics and Merck. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

Sangamo Biosciences

Parker Institute

Editas Medicine

Intellia Therapeutics

Thermo Fisher Scientific

Cellectis

Crispr Therapeutics

Merck Alma Lasers Ltd.

Some of the key questions answered by the report are:

What was the market size in 2014 and forecast from 2015 to 2025?

What will be the industry market growth from 2015 to 2025?

What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?

What are the major segments leading the market growth and why?

Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Table of Contents:

1. Introduction

1.1. Report Description

2. Executive Summary

2.1. Key Highlights

3. Market Overview

3.1. Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

4. Market Analysis by Regions

4.1. North America (United States, Canada and Mexico)

4.1.1. United States Market States and Outlook (2014-2025)

4.1.2. Canada Market States and Outlook (2014-2025)

4.1.3. Mexico Market States and Outlook (2014-2025)

4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1. Germany Market States and Outlook (2014-2025)

4.2.2. France Market States and Outlook (2014-2025)

4.2.3. UK Market States and Outlook (2014-2025)

4.2.4. Russia Market States and Outlook (2014-2025)

4.2.5. Italy Market States and Outlook (2014-2025)

4.2.6. Rest of Europe Market States and Outlook (2014-2025)

4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1. China Market States and Outlook (2014-2025)

4.3.2. Japan Market States and Outlook (2014-2025)

4.3.3. Korea Market States and Outlook (2014-2025)

4.3.4. India Market States and Outlook (2014-2025)

4.3.5. Southeast Asia Market States and Outlook (2014-2025)

4.3.6. Rest of Asia-Pacific Market States and Outlook (2014-2025)

4.4. South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1. Brazil Market States and Outlook (2014-2025)

4.4.2. Argentina Market States and Outlook (2014-2025)

4.4.3. Columbia Market States and Outlook (2014-2025)

4.4.4. Rest of South America Market States and Outlook (2014-2025)

4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1. Saudi Arabia Market States and Outlook (2014-2025)

4.5.2. United Arab Emirates Market States and Outlook (2014-2025)

4.5.3. Egypt Market States and Outlook (2014-2025)

4.5.4. Nigeria Market States and Outlook (2014-2025)

4.5.5. South Africa Market States and Outlook (2014-2025)

4.5.6. Turkey Market States and Outlook (2014-2025)

4.5.7. Rest of Middle East and Africa Market States and Outlook (2014-2025)

5. Gene Editing Market, By Product

5.1. Introduction

5.2. Global Gene Editing Revenue and Market Share by Product (2014-2018)

5.2.1. Global Gene Editing Revenue and Revenue Share by Product (2014-2018)

5.3. Instruments

5.3.1. Global Instruments Revenue and Growth Rate (2014-2018)

5.4. Cell Lines & Animal Models and Software

5.4.1. Global Cell Lines & Animal Models and Software Revenue and Growth Rate (2014-2018)

5.5. Reagents and Consumables

5.5.1. Global Reagents and Consumables Revenue and Growth Rate (2014-2018)

6. Gene Editing Market, By Technology

6.1. Introduction

6.2. Global Gene Editing Revenue and Market Share by Technology (2014-2018)

6.2.1. Global Gene Editing Revenue and Revenue Share by Technology (2014-2018)

6.3. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

6.3.1. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Revenue and Growth Rate (2014-2018)

6.4. Zinc Finger Nucleases (ZFN)

6.4.1. Global Zinc Finger Nucleases (ZFN) Revenue and Growth Rate (2014-2018)

6.5. Transcriptor-Activator-Like Effector Nuclease (TALEN)

6.5.1. Global Transcriptor-Activator-Like Effector Nuclease (TALEN) Revenue and Growth Rate (2014-2018)

6.6. Other

6.6.1. Global Other Revenue and Growth Rate (2014-2018)

7. Gene Editing Market, By Application

7.1. Introduction

7.2. Global Gene Editing Revenue and Market Share by Application (2014-2018)

7.2.1. Global Gene Editing Revenue and Revenue Share by Application (2014-2018)

7.3. Biotechnology

7.3.1. Global Biotechnology Revenue and Growth Rate (2014-2018)

7.4. Drug Discovery & Development

7.4.1. Global Drug Discovery & Development Revenue and Growth Rate (2014-2018)

7.5. Agriculture

7.5.1. Global Agriculture Revenue and Growth Rate (2014-2018)

7.6. Scientific Research

7.6.1. Global Scientific Research Revenue and Growth Rate (2014-2018)

8. Gene Editing Market, By Region

8.1. Introduction

8.2. Global Gene Editing Revenue and Market Share by Regions

8.2.1. Global Gene Editing Revenue by Regions (2014-2018)

8.3. North America Gene Editing by Countries

8.3.1. North America Gene Editing Revenue and Growth Rate (2014-2018)

8.3.2. North America Gene Editing Revenue (Million USD) by Countries (2014-2018)

8.3.3. United States

8.3.3.1. United States Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.4. Canada

8.3.4.1. Canada Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.5. Mexico

8.3.5.1. Mexico Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.4. Europe Gene Editing by Countries

8.4.1. Europe Gene Editing Revenue and Growth Rate (2014-2018)

8.4.2. Europe Gene Editing Revenue (Million USD) by Countries (2014-2018)

8.4.3. Germany

8.4.3.1. Germany Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.4. France

8.4.4.1. France Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.5. UK

8.4.5.1. UK Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.6. Russia

8.4.6.1. Russia Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.7. Italy

8.4.7.1. Italy Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.8. Rest of Europe

8.4.8.1. Rest of Europe Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.5. Asia-Pacific Gene Editing by Countries

8.5.1. Asia-Pacific Gene Editing Revenue and Growth Rate (2014-2018)

8.5.2. Asia-Pacific Gene Editing Revenue (Million USD) by Countries (2014-2018)

8.5.3. China

8.5.3.1. China Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.4. Japan

8.5.4.1. Japan Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.5. Korea

8.5.5.1. Korea Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.6. India

8.5.6.1. India Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.7. Southeast Asia

8.5.7.1. Southeast Asia Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.8. Rest of Asia-Pacific

8.5.8.1. Rest of Asia-Pacific Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.6. South America Gene Editing by Countries

8.6.1. South America Gene Editing Revenue and Growth Rate (2014-2018)

8.6.2. South America Gene Editing Revenue (Million USD) by Countries (2014-2018)

8.6.3. Brazil

8.6.3.1. Brazil Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.4. Argentina

8.6.4.1. Argentina Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.5. Columbia

8.6.5.1. Columbia Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.6. Rest of South America

8.6.6.1. Rest of South America Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.7. Middle East and Africa Gene Editing by Countries

8.7.1. Middle East and Africa Gene Editing Revenue and Growth Rate (2014-2018)

8.7.2. Middle East and Africa Gene Editing Revenue (Million USD) by Countries (2014-2018)

8.7.3. Saudi Arabia

8.7.3.1. Saudi Arabia Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.4. United Arab Emirates

8.7.4.1. United Arab Emirates Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.5. Egypt

8.7.5.1. Egypt Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.6. Nigeria

8.7.6.1. Nigeria Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.7. South Africa

8.7.7.1. South Africa Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.8. Turkey

8.7.8.1. Turkey Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.9. Rest of Middle East and Africa

8.7.9.1. Rest of Middle East and Africa Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

9. Company Profiles

9.1. Sangamo Biosciences

9.1.1. Business Overview

9.1.2. Service Portfolio

9.1.3. Strategic Developments

9.1.4. Revenue and Market Share

9.2. Parker Institute

9.2.1. Business Overview

9.2.2. Service Portfolio

9.2.3. Strategic Developments

9.2.4. Revenue and Market Share

9.3. Editas Medicine

9.3.1. Business Overview

9.3.2. Service Portfolio

9.3.3. Strategic Developments

9.3.4. Revenue and Market Share

9.4. Intellia Therapeutics

9.4.1. Business Overview

9.4.2. Service Portfolio

9.4.3. Strategic Developments

9.4.4. Revenue and Market Share

9.5. Thermo Fisher Scientific

9.5.1. Business Overview

9.5.2. Service Portfolio

9.5.3. Strategic Developments

9.5.4. Revenue and Market Share

9.6. Cellectis

9.6.1. Business Overview

9.6.2. Service Portfolio

9.6.3. Strategic Developments

9.6.4. Revenue and Market Share

9.7. Crispr Therapeutics

9.7.1. Business Overview

9.7.2. Service Portfolio

9.7.3. Strategic Developments

9.7.4. Revenue and Market Share

9.8. Merck Alma Lasers Ltd.

9.8.1. Business Overview

9.8.2. Service Portfolio

9.8.3. Strategic Developments

9.8.4. Revenue and Market Share

10. Global Gene Editing Market Competition, by Manufacturer

10.1. Global Gene Editing Revenue and Market Share by Manufacturer (2016-2017)

10.2. Global Gene Editing Price By Region (2016-2017)

10.3. Top 5 Gene Editing Manufacturer Market Share

10.4. Market Competition Trend

11. Gene Editing Market Forecast (2018-2025)

11.1. Global Gene Editing Revenue (Millions USD) and Growth Rate (2018-2025)

11.2. Gene Editing Market Forecast by Regions (2018-2025)

11.2.1. North America Gene Editing Market Forecast (2018-2025)

11.2.1.1. United States Gene Editing Market Forecast (2018-2025)

11.2.1.2. Canada Gene Editing Market Forecast (2018-2025)

11.2.1.3. Mexico Gene Editing Market Forecast (2018-2025)

11.2.2. Europe Gene Editing Market Forecast (2018-2025)

11.2.2.1. Germany Gene Editing Market Forecast (2018-2025)

11.2.2.2. France Gene Editing Market Forecast (2018-2025)

11.2.2.3. UK Gene Editing Market Forecast (2018-2025)

11.2.2.4. Russia Gene Editing Market Forecast (2018-2025)

11.2.2.5. Italy Gene Editing Market Forecast (2018-2025)

11.2.2.6. Rest of Europe Gene Editing Market Forecast (2018-2025)

11.2.3. Asia-Pacific Gene Editing Market Forecast (2018-2025)

11.2.3.1. China Gene Editing Market Forecast (2018-2025)

11.2.3.2. Japan Gene Editing Market Forecast (2018-2025)

11.2.3.3. Korea Gene Editing Market Forecast (2018-2025)

11.2.3.4. India Gene Editing Market Forecast (2018-2025)

11.2.3.5. Southeast Asia Gene Editing Market Forecast (2018-2025)

11.2.3.6. Rest of Asia-Pacific Gene Editing Market Forecast (2018-2025)

11.2.4. South America Gene Editing Market Forecast (2018-2025)

11.2.4.1. Brazil Gene Editing Market Forecast (2018-2025)

11.2.4.2. Argentina Gene Editing Market Forecast (2018-2025)

11.2.4.3. Columbia Gene Editing Market Forecast (2018-2025)

11.2.4.4. Rest of South America Gene Editing Market Forecast (2018-2025)

11.2.5. Middle East and Africa Gene Editing Market Forecast (2018-2025)

11.2.5.1. Saudi Arabia Gene Editing Market Forecast (2018-2025)

11.2.5.2. United Arab Emirates Gene Editing Market Forecast (2018-2025)

11.2.5.3. Egypt Gene Editing Market Forecast (2018-2025)

11.2.5.4. Nigeria Gene Editing Market Forecast (2018-2025)

11.2.5.5. South Africa Gene Editing Market Forecast (2018-2025)

11.2.5.6. Turkey Gene Editing Market Forecast (2018-2025)

11.2.5.7. Rest of Middle East and Africa Gene Editing Market Forecast (2018-2025)

11.3. Gene Editing Market Forecast by Product (2018-2025)

11.3.1. Gene Editing Forecast by Product (2018-2025)

11.3.2. Gene Editing Market Share Forecast by Product (2018-2025)

11.4. Gene Editing Market Forecast by Technology (2018-2025)

11.4.1. Gene Editing Forecast by Technology (2018-2025)

11.4.2. Gene Editing Market Share Forecast by Technology (2018-2025)

11.5. Gene Editing Market Forecast by Application (2018-2025)

11.5.1. Gene Editing Forecast by Application (2018-2025)

11.5.2. Gene Editing Market Share Forecast by Application (2018-2025)

List of Tables and Figures:

Figure United States Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Canada Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Mexico Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Germany Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure France Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure UK Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Russia Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Italy Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of Europe Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure China Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Japan Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Korea Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure India Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Southeast Asia Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of Asia-Pacific Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Brazil Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Argentina Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Columbia Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of South America Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Saudi Arabia Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure United Arab Emirates Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Egypt Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Nigeria Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure South Africa Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Turkey Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of Middle East and Africa Gene Editing Revenue (Million USD) and Growth Rate (2014-2025)

Table Global Gene Editing Revenue and Revenue Share by Product (2014-2018)

Figure Global Instruments Revenue and Growth Rate (2014-2018)

Figure Global Cell Lines & Animal Models and Software Revenue and Growth Rate (2014-2018)

Figure Global Reagents and Consumables Revenue and Growth Rate (2014-2018)

Table Global Gene Editing Revenue and Revenue Share by Technology (2014-2018)

Figure Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Revenue and Growth Rate (2014-2018)

Figure Global Zinc Finger Nucleases (ZFN) Revenue and Growth Rate (2014-2018)

Figure Global Transcriptor-Activator-Like Effector Nuclease (TALEN) Revenue and Growth Rate (2014-2018)

Figure Global Other Revenue and Growth Rate (2014-2018)

Table Global Gene Editing Revenue and Revenue Share by Application (2014-2018)

Figure Global Biotechnology Revenue and Growth Rate (2014-2018)

Figure Global Drug Discovery & Development Revenue and Growth Rate (2014-2018)

Figure Global Agriculture Revenue and Growth Rate (2014-2018)

Figure Global Scientific Research Revenue and Growth Rate (2014-2018)

Table Global Gene Editing Revenue by Regions (2014-2018)

Figure North America Gene Editing Growth Rate (2014-2018)

Figure North America Gene Editing Revenue and Growth Rate (2014-2018)

Figure North America Gene Editing by Countries (2014-2018)

Figure North America Gene Editing Revenue (Million USD) by Countries (2014-2018)

Figure United States Gene Editing Growth Rate (2014-2018)

Figure United States Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Canada Gene Editing Growth Rate (2014-2018)

Figure Canada Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Mexico Gene Editing Growth Rate (2014-2018)

Figure Mexico Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Europe Gene Editing Growth Rate (2014-2018)

Figure Europe Gene Editing Revenue and Growth Rate (2014-2018)

Figure Europe Gene Editing by Countries (2014-2018)

Figure Europe Gene Editing Revenue (Million USD) by Countries (2014-2018)

Figure Germany Gene Editing Growth Rate (2014-2018)

Figure Germany Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure France Gene Editing Growth Rate (2014-2018)

Figure France Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure UK Gene Editing Growth Rate (2014-2018)

Figure UK Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Russia Gene Editing Growth Rate (2014-2018)

Figure Russia Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Italy Gene Editing Growth Rate (2014-2018)

Figure Italy Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of Europe Gene Editing Growth Rate (2014-2018)

Figure Rest of Europe Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Asia-Pacific Gene Editing Growth Rate (2014-2018)

Figure Asia-Pacific Gene Editing Revenue and Growth Rate (2014-2018)

Figure Asia-Pacific Gene Editing by Countries (2014-2018)

Figure Asia-Pacific Gene Editing Revenue (Million USD) by Countries (2014-2018)

Figure China Gene Editing Growth Rate (2014-2018)

Figure China Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Japan Gene Editing Growth Rate (2014-2018)

Figure Japan Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Korea Gene Editing Growth Rate (2014-2018)

Figure Korea Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure India Gene Editing Growth Rate (2014-2018)

Figure India Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Southeast Asia Gene Editing Growth Rate (2014-2018)

Figure Southeast Asia Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of Asia-Pacific Gene Editing Growth Rate (2014-2018)

Figure Rest of Asia-Pacific Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure South America Gene Editing Growth Rate (2014-2018)

Figure South America Gene Editing Revenue and Growth Rate (2014-2018)

Figure South America Gene Editing by Countries (2014-2018)

Figure South America Gene Editing Revenue (Million USD) by Countries (2014-2018)

Figure Brazil Gene Editing Growth Rate (2014-2018)

Figure Brazil Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Argentina Gene Editing Growth Rate (2014-2018)

Figure Argentina Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Columbia Gene Editing Growth Rate (2014-2018)

Figure Columbia Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of South America Gene Editing Growth Rate (2014-2018)

Figure Rest of South America Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Middle East and Africa Gene Editing Growth Rate (2014-2018)

Figure Middle East and Africa Gene Editing Revenue and Growth Rate (2014-2018)

Figure Middle East and Africa Gene Editing by Countries (2014-2018)

Figure Middle East and Africa Gene Editing Revenue (Million USD) by Countries (2014-2018)

Figure Saudi Arabia Gene Editing Growth Rate (2014-2018)

Figure Saudi Arabia Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure United Arab Emirates Gene Editing Growth Rate (2014-2018)

Figure United Arab Emirates Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Egypt Gene Editing Growth Rate (2014-2018)

Figure Egypt Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Nigeria Gene Editing Growth Rate (2014-2018)

Figure Nigeria Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure South Africa Gene Editing Growth Rate (2014-2018)

Figure South Africa Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Turkey Gene Editing Growth Rate (2014-2018)

Figure Turkey Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of Middle East and Africa Gene Editing Growth Rate (2014-2018)

Figure Rest of Middle East and Africa Gene Editing Revenue (Millions USD) and Growth Rate (2014-2018)

Table Sangamo Biosciences Gene Editing Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Parker Institute Gene Editing Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Editas Medicine Gene Editing Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Intellia Therapeutics Gene Editing Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Thermo Fisher Scientific Gene Editing Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Cellectis Gene Editing Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Crispr Therapeutics Gene Editing Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Alma Lasers Ltd. Gene Editing Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Gene Editing Market Share by Manufacturer

Figure Global Gene Editing Revenue and Market Share by Manufacturer

Table Global Gene Editing Price by Region (2016-2017)

Figure Top 5 Gene Editing Manufacturer (Revenue) Market Share

Figure Market Competition Trend

Figure Global Gene Editing Revenue (Millions USD) and Growth Rate (2018-2025)

Table Gene Editing Market Forecast by Regions (2018-2025)

Figure North America Gene Editing Market Forecast (2018-2025)

Figure United States Gene Editing Market Forecast (2018-2025)

Figure Canada Gene Editing Market Forecast (2018-2025)

Figure Mexico Gene Editing Market Forecast (2018-2025)

Figure Europe Gene Editing Market Forecast (2018-2025)

Figure Germany Gene Editing Market Forecast (2018-2025)

Figure France Gene Editing Market Forecast (2018-2025)

Figure UK Gene Editing Market Forecast (2018-2025)

Figure Russia Gene Editing Market Forecast (2018-2025)

Figure Italy Gene Editing Market Forecast (2018-2025)

Figure Rest of Europe Gene Editing Market Forecast (2018-2025)

Figure Asia-Pacific Gene Editing Market Forecast (2018-2025)

Figure China Gene Editing Market Forecast (2018-2025)

Figure Japan Gene Editing Market Forecast (2018-2025)

Figure Korea Gene Editing Market Forecast (2018-2025)

Figure India Gene Editing Market Forecast (2018-2025)

Figure Southeast Asia Gene Editing Market Forecast (2018-2025)

Figure Rest of Asia-Pacific Gene Editing Market Forecast (2018-2025)

Figure South America Gene Editing Market Forecast (2018-2025)

Figure Brazil Gene Editing Market Forecast (2018-2025)

Figure Argentina Gene Editing Market Forecast (2018-2025)

Figure Columbia Gene Editing Market Forecast (2018-2025)

Figure Rest of South America Gene Editing Market Forecast (2018-2025)

Figure Middle East and Africa Gene Editing Market Forecast (2018-2025)

Figure Saudi Arabia Gene Editing Market Forecast (2018-2025)

Figure United Arab Emirates Gene Editing Market Forecast (2018-2025)

Figure Egypt Gene Editing Market Forecast (2018-2025)

Figure Nigeria Gene Editing Market Forecast (2018-2025)

Figure South Africa Gene Editing Market Forecast (2018-2025)

Figure Turkey Gene Editing Market Forecast (2018-2025)

Figure Rest of Middle East and Africa Gene Editing Market Forecast (2018-2025)

Figure Global Gene Editing Forecast by Product (2018-2025)

Figure Global Gene Editing Market Share Forecast by Product (2018-2025)

Figure Global Gene Editing Forecast by Product (2018-2025)

Figure Global Gene Editing Forecast by Technology (2018-2025)

Figure Global Gene Editing Market Share Forecast by Technology (2018-2025)

Figure Global Gene Editing Forecast by Technology (2018-2025)

Figure Global Gene Editing Forecast by Application (2018-2025)

Figure Global Gene Editing Market Share Forecast by Application (2018-2025)

Figure Global Gene Editing Forecast by Application (2018-2025)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices, and Others [Telepathology]), Type (Automated Hematology Analyzers & Blood Cell Counters, Chromosome Analyzers, FISH Enumeration Systems, Urine Sediment Analyzers, Immunohistochemistry Image Analysis Applications, Digital Cytopathology, Digital PCR, Signet Cell Detection, and Digital Holographic Microscopy), and End User (Educational, Clinical, and Pharma & Biotech Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...

  • Publish Date: February 26, 2018
  • $5370
View Details
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
View Details
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research